According to XBiotech's latest financial reports the company's current EPS (TTM) is -$0.94. In 2022 the company made an earnings per share (EPS) of -$1.08 a decrease over its 2021 EPS that were of -$0.58.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.94 | -12.96% |
2022 | -$1.08 | 86.21% |
2021 | -$0.58 | 48.57% |
2020 | -$0.39 | -102.27% |
2019 | $17.17 | -3060.34% |
2018 | -$0.58 | -41.41% |
2017 | -$0.99 | -39.26% |
2016 | -$1.63 | 37.46% |
2015 | -$1.19 | 73.13% |
2014 | -$0.68 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
uniQure QURE | -$3.94 | 319.15% | ๐ณ๐ฑ Netherlands |
Calithera Biosciences
CALA | -$5.43 | 477.66% | ๐บ๐ธ USA |
Enzo Biochem ENZ | -$0.94 | 0.00% | ๐บ๐ธ USA |